Literature DB >> 12878994

Echocardiographic and clinical characteristics of aortic regurgitation because of systemic vasculitis.

Jae-Kwan Song1, Young-Hoon Jeong, Duk-Hyun Kang, Jong-Min Song, Hyun Song, Suk Jung Choo, Jae Won Lee, Meong Gun Song.   

Abstract

BACKGROUND: Although systemic vasculitis has been described as one cause of aortic regurgitation (AR), clinical features of this disease entity have not been fully characterized.
METHODS: The clinical data of 153 consecutive patients (103 male), who underwent open-heart operation to correct predominant AR from January 1990 to December 2000 were retrospectively analyzed.
RESULTS: A total of 16 patients (10%) were found to have AR associated with systemic vasculitis; there were 9 patients with Takayasu's arteritis (TA) and 7 with Behçet's disease (BD). All patients with TA, but only 3 with BD, were female (P <.05). Echocardiography showed redundant motion of the elongated aortic cusp with the frequent periaortic echo-free space in BD, and characteristic motion limitation of thickened cusp with dilated and thickened aorta in TA. All patients with TA, but only 1 patient with BD, were given a diagnosis before operation (P <.05); the others underwent emergency operation to control acute AR of unknown etiology, and were given a correct diagnosis after detection of paravalvular leakage. In TA, paravalvular leakage developed in 1 patient (11%) and another died suddenly with chest pain. In BD, paravalvular leakage developed in 6 patients (86%) who needed repeated operation, and 2 died even after the third operation. The 2-year survival without clinical events (paravalvular leakage, repeated operation, or death) was 76 +/- 15% in TA and 14 +/- 13% in BD (P <.05).
CONCLUSIONS: TA and BD are 2 important causes of AR, and show different clinical features. A high rate of paravalvular leakage, especially in BD, warrants cautious systemic evaluations for the cause of AR, and characteristic echocardiographic findings seem to be helpful in the differential diagnosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12878994     DOI: 10.1067/S0894-7317(03)00406-1

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  6 in total

1.  Assessment of aortic stiffness and ventricular diastolic functions in patients with Behçet's disease.

Authors:  S Ercan Tunc; Abdullah Dogan; Omer Gedikli; Cagatay Arslan; Mehmet Sahin
Journal:  Rheumatol Int       Date:  2005-02-23       Impact factor: 2.631

2.  Aortic regurgitation caused by cusp bending of aortic valve leaflet.

Authors:  Kentaro Shibayama; Hiroyuki Watanabe; Tatsuya Murai; Shunsuke Sasaki; Minoru Tabata; Toshihiro Fukui; Jun Umemura; Shuichiro Takanashi; Tetsuya Sumiyoshi
Journal:  J Echocardiogr       Date:  2012-01-05

3.  Rapidly Progressive Cardiac Manifestation of Behçet's Disease Involving Conduction System and Aortic Valve.

Authors:  Jin Sok Yu; Eun Joo Cho; Eun Hye Ji; Hee Sun Kwon; Jin Seok Kim; Kyu Young Choi; Beom June Kwon; Dong Bin Kim; Seong Won Jang; Jae Hyung Kim
Journal:  J Cardiovasc Ultrasound       Date:  2011-12-27

4.  Predictors of paravalvular aortic regurgitation after surgery for Behcet's disease-related severe aortic regurgitation.

Authors:  Hong-Mi Choi; Hyung-Kwan Kim; Sung-Ji Park; Hyun-Jung Lee; Yeonyee E Yoon; Jun-Bean Park; Yong-Jin Kim; Goo-Young Cho; In-Chang Hwang; Dae-Won Sohn; Jae K Oh
Journal:  Orphanet J Rare Dis       Date:  2019-06-10       Impact factor: 4.123

5.  Risk factors of aortic regurgitation progression in Chinese patients with Takayasu's arteritis: a prospective cohort study.

Authors:  Yujiao Wang; Lili Ma; Ying Sun; Wensu Yu; Sifan Wu; Huiyong Chen; Xiaomin Dai; Lingying Ma; Lindi Jiang
Journal:  Ther Adv Chronic Dis       Date:  2022-10-05       Impact factor: 4.970

6.  Perioperative management with biologics on severe aortic valve regurgitation caused by Behçet syndrome: the experience from a single center.

Authors:  Luxi Sun; Jinjing Liu; Xiufeng Jin; Zhimian Wang; Lu Li; Wei Bai; Yunjiao Yang; Chanyuan Wu; Wei Chen; Shangdong Xu; Jun Zheng; Wenjie Zheng
Journal:  Ther Adv Chronic Dis       Date:  2021-06-22       Impact factor: 5.091

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.